Contributes to improving the accuracy of the development, validation, and implementation of molecular assays, as well as reducing labor costs. Customization is also possible.
We provide various standard materials from ZeptoMetrix that assist in the development, validation, and implementation of molecular assays related to oncology. Customization is also possible to meet laboratory needs. Please utilize them for obtaining consistent and accurate results in validation, inter-lot testing, and regular quality control. 【Features】 'Human DNA Deletion Plasma' - Standard materials can be produced tailored to specific time-limited needs while retaining the natural components of the sample. - Suppresses background DNA noise in plasma. 'Cell-free DNA (cfDNA) Control' - Can be used for performance evaluation of assays detecting somatic mutations in cfDNA through PCR, next-generation sequencing (NGS), and other novel readout methods. - Contributes to ensuring the accuracy of high-sensitivity assays necessary for detecting cfDNA in plasma. *In Japan, these are reagents for research purposes. Please refer to the materials for more details. Feel free to contact us with any inquiries.
Inquire About This Product
basic information
【Lineup and Specifications】 'Human DNA Deletion Plasma' ◎5mL ◎50mL ◎100mL ◎500mL ◎1000mL 'Cell-free DNA (cfDNA) Control' ◎ Multiplexed ctDNA fragments mixed with fragmented wild-type cfDNA background - 1μg in TE buffer, 3% AF - 125ng in 5mL plasma, 3% AF ◎ Normal female cfDNA standard - 1μg in TE buffer - 250ng spiked into 5mL plasma, wild-type background *Additionally, we also offer cell-derived variants compatible with amplicon and capture methods. For more details, please refer to the materials. Feel free to contact us with any inquiries.
Price range
Delivery Time
Applications/Examples of results
*For more details, please refer to the materials. Feel free to contact us as well.*
catalog（1）
Download All Catalogs
Company information
Bairokquest Co., Ltd. is a company that provides a wide range of services to all researchers active at the forefront of life sciences. Our company was established on July 30, 2008, to engage more deeply, actively, and professionally in the infectious disease market and the biochemical specialty reagent market, starting with the introduction of HIV-related reagents to the Japanese market from Europe and the United States. Since then, we have actively imported and sold a variety of infectious disease-related products and biochemical specialty reagents, while also providing services for overseas information related to infectious diseases and biochemistry. We handle products such as viral genetic control NATtrol, clinical samples, and offer various human-derived tissues, cancer specimens, and clinical specimens (healthy individuals/patients: plasma, serum, cerebrospinal fluid, urine, etc.), as well as various contract collection services. Please feel free to contact us when you need our services.
